Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 16,52116,540 of 20,252 grants

Active NON-SBIR/STTR RPGS
Ethnicity and Lung Cancer Survival: A Test of the Hispanic Sociocultural Hypothesis
NATIONAL CANCER INSTITUTE University of Arizona United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT As the leading cause of cancer death, lung cancer represents the most significant cancer-related public health challenge in the United States.Although low-...

$7.42M
USD
Active NON-SBIR/STTR RPGS
Urine based circulating tumor DNA analysis
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2021 – 2026

ABSTRACT Urine is an underappreciated source for systemic circulating tumor DNA in patients with non-genitourinary cancers.Based on recent data suggesting that blood-based HPV DNA...

$4.55M
USD
Active NON-SBIR/STTR RPGS
A pro-metastatic secretory pathway activated by p53 loss in lung cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

Cancer cells are embedded in a protective and nourishing ?niche?, an environment that cancer cells create by secreting proteins into their surroundings.Because cancer cells depend...

$4.34M
USD
Active NON-SBIR/STTR RPGS
Regulation of DNA replication kinetics by BRCA2 after DNA damage
NATIONAL CANCER INSTITUTE Rbhs -Cancer Institute of New Jersey United States 2021 – 2026

Germline mutations in BRCA2 predispose carriers to breast, ovarian, pancreatic, and other cancers.The gene encodes a very large protein that plays critical roles in genome integrit...

$3.45M
USD
Active NON-SBIR/STTR RPGS
Innate Immune Mechanisms Contributing to Cancer Growth in Obesity
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2026

Project Summary/Abstract Colorectal cancer (CRC) is the second leading cause of cancer mortality in the United States, and obesity, which affects 40% of the population, not only in...

$5.26M
USD
Active NON-SBIR/STTR RPGS
Statistical methods for cancer mutational signatures
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2026

Project Summary Carcinogens and evolutionary pressures generate unique patterns in the types of somatic mutations observed in the DNA of cancer cells. Mutational signature analysis...

$4.17M
USD
Active NON-SBIR/STTR RPGS
Targeting cellular double-stranded RNA homeostasis in breast cancer
NATIONAL CANCER INSTITUTE Georgetown University United States 2021 – 2026

Summary/Abstract The immunologically inactive (cold) tumor is a major challenge for effective immunotherapies in many cancers, including breast cancer.Increasing evidence has demon...

$3.74M
USD
Active NON-SBIR/STTR RPGS
Androgen receptor pathway inhibition through targeting PARP-2 in castration-resistant prostate cancer
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2021 – 2026

ABSTRACT Androgen receptor (AR) is ligand-activated transcription factor and a driver of prostate cancer (PCa).Understanding the molecular mechanisms of AR-mediated transcription i...

$4.09M
USD
Active NON-SBIR/STTR RPGS
Elucidating the Roles of RNA m6A readers Y1 and Y2 in radiation-induced immunity and immunotherapy
NATIONAL CANCER INSTITUTE University of Chicago United States 2021 – 2026

Project Summary Cancer is a leading cause of death worldwide.Recent advancements in the use of immune checkpoint blockade have transformed oncology, and immunotherapy has extended...

$4.13M
USD
Active NON-SBIR/STTR RPGS
The role of CEACAM1 in oncogenic B-cell receptor signaling and immunotherapy in mantle cell lymphoma
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2021 – 2026

Abstract Mantle cell lymphoma (MCL) accounts for 6-8% of all non-Hodgkin lymphomas (NHLs).While substantial therapeutic advances have been achieved for other NHLs, MCL remains an i...

$4.19M
USD
Completed OTHER RESEARCH-RELATED
Novel regulation of the CDK4/Cdh1/Pin1 signaling axis for targeted breast cancer therapies
NATIONAL CANCER INSTITUTE Beth Israel Deaconess Medical Center United States 2021 – 2023

Project Summary/Abstract: The anaphase-promoting complex/Cyclosome (APC/C) is a well-defined multi-subunit E3 ubiquitin ligase that regulates targeted cell cycle regulators for deg...

$1.7M
USD
Completed NON-SBIR/STTR RPGS
3D Ultra-sensitive Ultrasound Microvessel Imaging for Breast Mass Differentiation
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2021 – 2023

PROJECT SUMMARY Breast cancer, the second-leading cause of cancer deaths among women, affects millions of Americans. Early cancer detection and accurate tumor diagnosis are crucial...

$795K
USD
Active OTHER RESEARCH-RELATED
Defining PARP Inhibitor Response and Resistance in Prostate Cancer
NATIONAL CANCER INSTITUTE University of California At Davis United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT The objective of this K01 award is to promote the development of Dr. Alan Lombard into an independent prostate cancer researcher. The proposed project will...

$1.67M
USD
Completed OTHER RESEARCH-RELATED
Investigating Cellular Communication in the Tumor Microenvironment in Pancreatic Cancer
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2021 – 2022

PROJECT SUMMARY/ABSTRACT Pancreatic ductal adenocarcinoma (PDA) is projected to become the 2nd leading cause of cancer-related deaths world-wide by 2030, largely due a lack of effe...

$1.35M
USD
Completed NON-SBIR/STTR RPGS
Novel strategy combined with targeted radiation therapy unleashes potent antitumor immunity in HPV + head and neck cancer
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2023

Project Summary/Abstract The overwhelming public health burden of HPV-associated head and neck cancer (HNC) has created great demand for novel, broadly effective therapies with red...

$2.3M
USD
Active NON-SBIR/STTR RPGS
Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2021 – 2026

Chemotherapy-related cognitive impairment (CRCI, chemobrain), chemotherapy-induced peripheral neuropathy (CIPN) and gait changes are debilitating side-effects of cancer treatment w...

$6.35M
USD
Completed NON-SBIR/STTR RPGS
Anti-tumor efficacy of novel cGAS-STING pathway agonists
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2021 – 2023

PROJECT SUMMARY The goal of this proposal is a molecular and immunological examination of novel compounds that activate innate immune signaling mediated by the proteins cyclic GMP-...

$1.95M
USD
Completed NON-SBIR/STTR RPGS
Engineered Enteric Nervous System-Peri Neural Invasion platform to improve predictive preclinical screens in early-stage colorectal adenocarcinomas
NATIONAL CANCER INSTITUTE Texas Engineering Experiment Station United States 2021 – 2023

PROJECT SUMMARY The objective of this proposal is to engineer and utilize enteric nerve plexi as a tool to improve predictive accuracy of preclinical screens in early stage II-III...

$2.2M
USD
Completed NON-SBIR/STTR RPGS
Fatty acid synthase in regulation of UDP-GlcNAc synthesis in colorectal cancer
NATIONAL CANCER INSTITUTE University of Kentucky United States 2021 – 2023

PROJECT SUMMARY Altered metabolism is rapidly emerging as a target for therapeutic intervention in cancer.An increased rate of lipid synthesis in cancer has been recognized as an i...

$765K
USD
Completed NON-SBIR/STTR RPGS
Therapeutic potential of targeting DNA repair deficiency in TSC
NATIONAL CANCER INSTITUTE Michigan State University United States 2021 – 2023

PROJECT SUMMARY/ ABSTRACT Using next-generation sequencing, researchers have identified somatic mutations as essential for tumor etiology and evolution. We now know that many cance...

$2.19M
USD